Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC
Clinical trial NCT04161352 · UNKNOWN
Trial details
- NCT number
- NCT04161352
- Sponsor
- Zhejiang Cancer Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-25
- Primary completion
- 2022-06-30
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.